Efficacy of T-HEMOVINE as Topical Hemostatic Agent: A Clinical Study

Abstract

AIM: Clinical trials using hemostatic T-Hemovine derived from bovine gelatin, to stop bleeding during surgery was performed. METHODS: Twenty (20) patients (aged 8 months–70 years) who underwent neurosurgery at Dr. Wahidin Sudirohusodo Hospital and Hasanuddin University Teaching Hospital, from September 16, to December 13, 2019, are willing to receive T-Hemovine to control bleeding. RESULTS: This approach was successfully used in twenty patients. Four patients stopped bleeding at the 3rd min (20%), nineteen patients stopped bleeding at the 5th min or less (95%) and twenty patients stopped bleeding before the 10th min (100%). There were no post-operative bleeding events, no infection, and no other post-operative complications. CONCLUSION: Therefore, there is no effect, and the safety of using T-Hemovine hemostatic is the same as the effect and safety of using surgeon hemostatic and other hemostatic.